Citations (101)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Cihan Karadağ, Bertan Akar, Gökçenur Gönenç, Reyhan Aslancan, Nagihan Yılmaz & Eray Çalışkan. (2020) Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation. The Journal of Maternal-Fetal & Neonatal Medicine 33:11, pages 1934-1939.
Read now
Read now
Tracy E. Dudding & John Attia. (2012) Maternal factor V Leiden and adverse pregnancy outcome: deciding whether or not to test. The Journal of Maternal-Fetal & Neonatal Medicine 25:7, pages 889-894.
Read now
Read now
Michael J. Kupferminc, Eli Rimon, Ariel Many, Maslovitz Sharon, Joseph B. Lessing & Ronni Gamzu. (2011) Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications. The Journal of Maternal-Fetal & Neonatal Medicine 24:8, pages 1042-1045.
Read now
Read now
A. Sucak, K. Acar, Ş. Çelen, N. Danisman & G. T. Sucak. (2010) Outcome of pregnancies in women with thrombophilic disorders. Journal of Obstetrics and Gynaecology 30:8, pages 847-851.
Read now
Read now
Nina Raju & Shannon M Bates. (2009) Preventing thrombophilia-related complications of pregnancy. Expert Review of Hematology 2:2, pages 183-196.
Read now
Read now
Adi Y Weintraub, Fernanda Press, Arnon Wiznitzer & Eyal Sheiner. (2007) Maternal thrombophilia and adverse pregnancy outcomes. Expert Review of Obstetrics & Gynecology 2:2, pages 203-216.
Read now
Read now
Roberto Romero, Gustaaf Dekker, Michael Kupferminc, George Saade, Jeffrey Livingston, Alan Peaceman, Moshe Mazor, Bo Hyun Yoon, Jimmy Espinoza, Tinnakorn Chaiworapongsa, Ricardo Gomez, Fernando Arias & Baha Sibai. (2002) Can heparin prevent adverse pregnancy outcome?. The Journal of Maternal-Fetal & Neonatal Medicine 12:1, pages 1-8.
Read now
Read now
Articles from other publishers (94)
Richika Ganjoo, Shveta Sharma, Chandrabhan Verma, M.A. Quraishi & Ashish Kumar. (2023) Heteropolysaccharides in sustainable corrosion inhibition: 4E (Energy, Economy, Ecology, and Effectivity) dimensions. International Journal of Biological Macromolecules 235, pages 123571.
Crossref
Crossref
Petronela Vicoveanu, Ingrid Andrada Vasilache, Ioana Sadiye Scripcariu, Dragos Nemescu, Alexandru Carauleanu, Dragos Vicoveanu, Ana Roxana Covali, Catalina Filip & Demetra Socolov. (2022) Use of a Feed-Forward Back Propagation Network for the Prediction of Small for Gestational Age Newborns in a Cohort of Pregnant Patients with Thrombophilia. Diagnostics 12:4, pages 1009.
Crossref
Crossref
Monica Cruz-Lemini, Juan Carlos Vázquez, Johana Ullmo & Elisa Llurba. (2022) Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 226:2, pages S1126-S1144.e17.
Crossref
Crossref
Rawan Nahas, Walid Saliba, Adi Elias & Mazen Elias. (2016) The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages. Clinical and Applied Thrombosis/Hemostasis 24:1, pages 122-128.
Crossref
Crossref
Amihai Rottenstreich, Hagai Amsalem, Geffen Kleinstern & Yosef Kalish. (2017) Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss. Reproductive BioMedicine Online 35:4, pages 461-467.
Crossref
Crossref
C. Karadağ, T. Yoldemir, S. D. Karadağ, C. İnan, Z. N. Dolgun & L. Aslanova. (2017) Obstetric outcomes of recurrent pregnancy loss patients diagnosed wıth inherited thrombophilia. Irish Journal of Medical Science (1971 -) 186:3, pages 707-713.
Crossref
Crossref
BASSAM HADDAD, EDOUARD LECARPENTIER, CYRIL TOUBOUL & BAHA M. SIBAI. (2017) Low–Molecular-Weight Heparin for the Prevention of Placenta-mediated Pregnancy Complications. Clinical Obstetrics & Gynecology 60:1, pages 153-160.
Crossref
Crossref
Katie M. Groom, Lesley M. McCowan, Laura K. Mackay, Arier C. Lee, Joanne M. Said, Stefan C. Kane, Susan P. Walker, Thijs E. van Mens, Natalie J. Hannan, Stephen Tong, Larry W. Chamley, Peter R. Stone, Claire McLintock, K. Groom, L. McCowan, L. Mackay, A. Lee, P. Stone, L. Chamley, C. McLintock, J. Said, S. Kane, S. Walker, S. Tong, N. Hannan, J. Said, T. van Mens, W. Ganzevoort & S. Middeldorp. (2017) Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial. American Journal of Obstetrics and Gynecology 216:3, pages 296.e1-296.e14.
Crossref
Crossref
K. M. Groom, L. M. McCowan, P. R. Stone, L. C. Chamley & C. McLintock. (2016) Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history – an open-label randomised trial (the EPPI trial): study protocol. BMC Pregnancy and Childbirth 16:1.
Crossref
Crossref
Elvira Grandone, Elena Chinni, Michela Villani, Natale Sciannamè, Giovanni L. Tiscia, Giovanni Favuzzi, Filomena Cappucci, Francesco Petruzzelli & Maurizio Margaglione. (2016) Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins. Archives of Gynecology and Obstetrics 294:6, pages 1323-1329.
Crossref
Crossref
Bassam Haddad, Norbert Winer, Yvon Chitrit, Véronique Houfflin-Debarge, Céline Chauleur, Karine Bages, Vassilis Tsatsaris, Alexandra Benachi, Florence Bretelle, Jean-Christophe Gris & Sylvie Bastuji-Garin. (2016) Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications. Obstetrics & Gynecology 128:5, pages 1053-1063.
Crossref
Crossref
Salvatore Andrea Mastrolia, Moshe Mazor, Gershon Holcberg, Elad Leron, Ofer Beharier, Giuseppe Loverro & Offer Erez. (2017) The physiologic anticoagulant and anti-inflammatory role of heparins and their utility in the prevention of pregnancy complications. Thrombosis and Haemostasis 113:06, pages 1236-1246.
Crossref
Crossref
Ilknur Mutlu, Mehmet Firat Mutlu, Aydan Biri, Berk Bulut, Mehmet Erdem & Ahmet Erdem. (2015) Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history. Blood Coagulation & Fibrinolysis 26:3, pages 267-273.
Crossref
Crossref
Michela Quaranta, Offer Erez, Salvatore Andrea Mastrolia, Arie Koifman, Elad Leron, Tamar Eshkoli, Moshe Mazor & Gershon Holcberg. (2015) The physiologic and therapeutic role of heparin in implantation and placentation. PeerJ 3, pages e691.
Crossref
Crossref
Anne Cathrine Staff, Baha M. Sibai & F.Gary Cunningham. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
253
267
.
Sukrutha Veerareddy, Katherine Clesham, Hannah Cohen & Donald Peebles. 2015. Disorders of Thrombosis and Hemostasis in Pregnancy. Disorders of Thrombosis and Hemostasis in Pregnancy
139
158
.
Marc A Rodger, William M Hague, John Kingdom, Susan R Kahn, Alan Karovitch, Mathew Sermer, Anne Marie Clement, Suzette Coat, Wee Shian Chan, Joanne Said, Evelyne Rey, Sue Robinson, Rshmi Khurana, Christine Demers, Michael J Kovacs, Susan Solymoss, Kim Hinshaw, James Dwyer, Graeme Smith, Sarah McDonald, Jill Newstead-Angel, Anne McLeod, Meena Khandelwal, Robert M Silver, Gregoire Le Gal, Ian A Greer, Erin Keely, Karen Rosene-Montella, Mark Walker & Philip S Wells. (2014) Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. The Lancet 384:9955, pages 1673-1683.
Crossref
Crossref
Alessandro Ghidini. (2014) Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation. Prenatal Diagnosis 34:7, pages 649-654.
Crossref
Crossref
Marianna Pina Rambaldi, Federico Mecacci, Secondo Guaschino & Michael J. Paidas. (2014) Inherited and Acquired Thrombophilias. Reproductive Sciences 21:2, pages 167-182.
Crossref
Crossref
Henning Hagmann, Verena Bossung, Abdel Ali Belaidi, Alexander Fridman, S. Ananth Karumanchi, Ravi Thadhani, Bernhard Schermer, Peter Mallmann, Guenter Schwarz, Thomas Benzing & Paul T. Brinkkoetter. (2014) Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination. PLoS ONE 9:1, pages e85258.
Crossref
Crossref
Paulien G. de Jong, Mariëtte Goddijn & Saskia Middeldorp. (2013) Antithrombotic therapy for pregnancy loss. Human Reproduction Update 19:6, pages 656-673.
Crossref
Crossref
Fabiana K. Marques, Fernanda M. F. Campos, Lirlândia P. Sousa, Andréa Teixeira-Carvalho, Luci M. S. Dusse & Karina B. Gomes. (2013) Association of microparticles and preeclampsia. Molecular Biology Reports 40:7, pages 4553-4559.
Crossref
Crossref
Wei-wei Chang, Xiao-ping Xia & Yun-xia Cao. (2013) Response to Xuan. Hypertension Research 36:5, pages 465-466.
Crossref
Crossref
Chao Xuan & Li-Min Lun. (2013) Association between the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to preeclampsia: the need for data clarification in a recent meta-analysis. Hypertension Research 36:5, pages 463-464.
Crossref
Crossref
Xi-mei Wang, Hai-yan Wu & Xu-jun Qiu. (2013) Methylenetetrahydrofolate Reductase (MTHFR) Gene C677T Polymorphism and Risk of Preeclampsia: An Updated Meta-analysis Based on 51 Studies. Archives of Medical Research 44:3, pages 159-168.
Crossref
Crossref
W. Rath & C. J. Thaler. (2017) Hereditäre Thrombophilien und Plazenta-medierte Schwangerschafts-komplikationen im II./III. Trimenon. Hämostaseologie 33:01, pages 21-36.
Crossref
Crossref
Shannon M. Bates. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
627
647
.
Chiara Tersigni, Riccardo Marana, Amparo Santamarìa, Roberta Castellani, Giovanni Scambia & Nicoletta Di Simone. (2012) In Vitro Evidences of Heparin’s Effects on Embryo Implantation and Trophoblast Development. Reproductive Sciences 19:5, pages 454-462.
Crossref
Crossref
Eli Rimon, Jessica Ascher-Landsberg, Noga Carmi, Ariel Many, Varda Deutsch & Michael J. Kupferminc. (2012) Severe pregnancy complications are associated with elevated factor VIII plasma activity. Blood Coagulation & Fibrinolysis 23:3, pages 184-188.
Crossref
Crossref
Shannon M. Bates, Ian A. Greer, Saskia Middeldorp, David L. Veenstra, Anne-Marie Prabulos & Per Olav Vandvik. (2012) VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy. Chest 141:2, pages e691S-e736S.
Crossref
Crossref
Sukrutha Veerareddy & Donald Peebles. 2012. Disorders of Thrombosis and Hemostasis in Pregnancy. Disorders of Thrombosis and Hemostasis in Pregnancy
83
97
.
Silvia D’Ippolito, Amparo Santamaria Ortiz, Manuela Veglia, Chiara Tersigni & Nicoletta Di Simone. (2011) Low Molecular Weight Heparin in Obstetric Care: A Review of the Literature. Reproductive Sciences 18:7, pages 602-613.
Crossref
Crossref
Michael Kupferminc, Eli Rimon, Ariel Many, Sharon Maslovitz, Joseph B Lessing & Ronni Gamzu. (2011) Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia. Blood Coagulation & Fibrinolysis 22:2, pages 123-126.
Crossref
Crossref
Christina S. Han, Michael J. Paidas & Charles J. Lockwood. 2011. High Risk Pregnancy. High Risk Pregnancy
739
752.e5
.
Charles J. Glueck, Joel Pranikoff, Naseer Khan, Kashif Riaz, Kirti Chavan, Pavithra Raj, Muhammad Umar & Ping Wang. (2010) High factor XI, recurrent pregnancy loss, enoxaparin. Fertility and Sterility 94:7, pages 2828-2831.
Crossref
Crossref
Michael J. Paidas, Christina S. Han, Nazli Hossain & Charles J. Lockwood. 2010. Hemostasis and Thrombosis in Obstetrics & Gynecology. Hemostasis and Thrombosis in Obstetrics & Gynecology
67
110
.
P. Deruelle, J.-M. Girard, N. Coutty & D. Subtil. (2010) Prévention de la prééclampsie. Annales Françaises d'Anesthésie et de Réanimation 29:3, pages e31-e35.
Crossref
Crossref
Eric Verspyck, Jeanne-Yvonne Borg, Horace Roman, Bernard Thobois, Patrick Pia & Loïc Marpeau. (2010) Hereditary thrombophilia and recurrence of ischemic placental disease. American Journal of Obstetrics and Gynecology 202:1, pages 54.e1-54.e5.
Crossref
Crossref
Silke MonienOliver Kadecki, Susanne Baumgarten, Abdulgabar Salama, Thomas Dörner & Holger Kiesewetter. (2009) Use of Heparin in Women With Early and Late Miscarriages With and Without Thrombophilia. Clinical and Applied Thrombosis/Hemostasis 15:6, pages 636-644.
Crossref
Crossref
Nazli Hossain, Frederick Schatz & Michael J. Paidas. (2009) Heparin and maternal fetal interface: Why should it work to prevent pregnancy complications?. Thrombosis Research 124:6, pages 653-655.
Crossref
Crossref
Vi Dao & Marc Rodger. (2009) Anticoagulants to prevent placenta-mediated pregnancy complications: a review of current evidence. Current Opinion in Hematology 16:5, pages 386-390.
Crossref
Crossref
Shannon M. Bates. 2009. New Therapeutic Agents in Thrombosis and Thrombolysis. New Therapeutic Agents in Thrombosis and Thrombolysis
197
220
.
Nathan P. Clark, Thomas Delate, Daniel M. Witt, Suzanne Parker & Robert McDuffie. (2008) A descriptive evaluation of unfractionated heparin use during pregnancy. Journal of Thrombosis and Thrombolysis 27:3, pages 267-273.
Crossref
Crossref
Abeer EddibJohn Yeh. (2009) Prevention of Preeclampsia: Is it Still a Disappointment?. Clinical medicine. Women's health 2, pages CMWH.S2385.
Crossref
Crossref
Ganga Ramidi, Naseer Khan, Charles J. Glueck, Ping Wang & Naila Goldenberg. (2009) Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss. Translational Research 153:1, pages 33-43.
Crossref
Crossref
Ingrid Pabinger. (2009) Thrombophilia and its impact on pregnancy. Thrombosis Research 123, pages S16-S21.
Crossref
Crossref
P. Deruelle, J.-M. Girard, N. Coutty & D. Subtil. 2009. Prise en charge multidisciplinaire de la prééclampsie. Prise en charge multidisciplinaire de la prééclampsie
57
66
.
Charles J. Lockwood & Robert M. Silver. 2009. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice
825
854
.
Baha M. Sibai & F. Gary Cunningham. 2009. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
213
225
.
John R. Barton & Baha M. Sibai. (2008) Prediction and Prevention of Recurrent Preeclampsia. Obstetrics & Gynecology 112:2, pages 359-372.
Crossref
Crossref
Shannon M. Bates, Ian A. Greer, Ingrid Pabinger, Shoshanna Sofaer & Jack Hirsh. (2008) Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy. Chest 133:6, pages 844S-886S.
Crossref
Crossref
N. Winer & V. Tsasaris. (2008) État des connaissances : prise en charge thérapeutique de la prééclampsie. La Revue Sage-Femme 7:1, pages 27-37.
Crossref
Crossref
N. Winer & V. Tsasaris. (2008) État des connaissances : prise en charge thérapeutique de la prééclampsie. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 37:1, pages 5-15.
Crossref
Crossref
Charles J. Glueck, Srikant Gogenini, Jitender Munjal, Trent Tracy, Joel Pranikoff & Ping Wang. (2008) Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss. Fertility and Sterility 89:2, pages 410-416.
Crossref
Crossref
Lisa Hui & Daniel Challis. (2008) Diagnosis and management of fetal growth restriction: the role of fetal therapy. Best Practice & Research Clinical Obstetrics & Gynaecology 22:1, pages 139-158.
Crossref
Crossref
Philippe Deruelle & Capucine Coulon. (2007) The use of low-molecular-weight heparins in pregnancy – how safe are they?. Current Opinion in Obstetrics & Gynecology 19:6, pages 573-577.
Crossref
Crossref
Benjamin Brenner & Anat Aharon. (2007) Thrombophilia and Adverse Pregnancy Outcome. Clinics in Perinatology 34:4, pages 527-541.
Crossref
Crossref
Adam J. Duhl, Michael J. Paidas, Serdar H. Ural, Ware Branch, Holly Casele, Joan Cox-Gill, Sheri Lynn Hamersley, Thomas M. Hyers, Vern Katz, Randall Kuhlmann, Edith A. Nutescu, James A. Thorp & James L. Zehnder. (2007) Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology 197:5, pages 457.e1-457.e21.
Crossref
Crossref
Adi Y. Weintraub & Eyal Sheiner. (2007) Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia. Archives of Gynecology and Obstetrics 276:6, pages 567-571.
Crossref
Crossref
Line Leduc, Emmanuelle Dubois, Larissa Takser, Evelyne Rey & Michèle David. (2007) Dalteparin and Low-Dose Aspirin in the Prevention of Adverse Obstetric Outcomes in Women With Inherited Thrombophilia. Journal of Obstetrics and Gynaecology Canada 29:10, pages 787-793.
Crossref
Crossref
S. MIDDELDORP. (2007) Thrombophilia and pregnancy complications: cause or association?. Journal of Thrombosis and Haemostasis 5, pages 276-282.
Crossref
Crossref
Gary A. DildyIIIIII, Michael A. Belfort & John C. Smulian. (2007) Preeclampsia Recurrence and Prevention. Seminars in Perinatology 31:3, pages 135-141.
Crossref
Crossref
Wendy L. Kinzler & Lillian Kaminsky. (2007) Fetal Growth Restriction and Subsequent Pregnancy Risks. Seminars in Perinatology 31:3, pages 126-134.
Crossref
Crossref
Michael J. Paidas. 2007. Management of High‐Risk Pregnancy. Management of High‐Risk Pregnancy
119
132
.
Luci Maria SantAna Dusse, Alan J. Cooper & Bashir A. Lwaleed. (2007) Thrombin activatable fibrinolysis inhibitor (TAFI): A role in pre-eclampsia?. Clinica Chimica Acta 378:1-2, pages 1-6.
Crossref
Crossref
Jody L. Kujovich & Barbara M. Alving. 2007. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
593
609
.
Baha M. Sibai. 2007. Obstetrics: Normal and Problem Pregnancies. Obstetrics: Normal and Problem Pregnancies
863
912
.
Michael J. Paidas, Christian M. Pettker & Charles J. Lockwood. 2007. Clinical Obstetrics. Clinical Obstetrics
825
848
.
CAROLINE L. STELLA & BAHA M. SIBAI. (2006) Thrombophilia and Adverse Maternal-Perinatal Outcome. Clinical Obstetrics & Gynecology 49:4, pages 850-860.
Crossref
Crossref
Benjamin Brenner. (2006) Thrombophilia and Adverse Pregnancy Outcome. Obstetrics and Gynecology Clinics of North America 33:3, pages 443-456.
Crossref
Crossref
Mordechai Dolitzky, Aida Inbal, Yakov Segal, Amir Weiss, Benjamin Brenner & Howard Carp. (2006) A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility 86:2, pages 362-366.
Crossref
Crossref
K. Haram, E. Søfteland & R. Bukowski. (2006) Intrauterine growth restriction. International Journal of Gynecology & Obstetrics 93:1, pages 5-12.
Crossref
Crossref
Charles J. Glueck, Joel Pranikoff, Dawit Aregawi, Mofiz Haque, Binghua Zhu, Trent Tracy & Ping Wang. (2005) The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage. Metabolism 54:10, pages 1345-1349.
Crossref
Crossref
I. PABINGER & R. VORMITTAG. (2005) Thrombophilia and pregnancy outcomes. Journal of Thrombosis and Haemostasis 3:8, pages 1603-1610.
Crossref
Crossref
Ian A. GreerCatherine Nelson-Piercy. (2005) Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106:2, pages 401-407.
Crossref
Crossref
Amy E. Sullivan, Lesa Nelson, Juhree A. Rice, T. Flint Porter, D. Ware Branch & Robert M. Silver. (2005) The Factor V Leiden and the G20210A Prothrombin Gene Mutations are Rare in Women with Fetal Death. American Journal of Reproductive Immunology 54:1, pages 1-4.
Crossref
Crossref
Michael J Kupferminc. (2005) Thrombophilia and Preeclampsia: The Evidence So Far. Clinical Obstetrics and Gynecology 48:2, pages 406-415.
Crossref
Crossref
Michael J. Paidas, De-Hui W. Ku, Jens Langhoff-Roos & Yale S. Arkel. (2005) Inherited Thrombophilias and Adverse Pregnancy Outcome: Screening and Management. Seminars in Perinatology 29:3, pages 150-163.
Crossref
Crossref
Baha Sibai, Gus Dekker & Michael Kupferminc. (2005) Pre-eclampsia. The Lancet 365:9461, pages 785-799.
Crossref
Crossref
Giorgio MelloElena ParrettiCinzia FatiniChiara RivielloFrancesca GensiniMauro MarchionniGian Franco ScarselliGian Franco GensiniRosanna Abbate. (2005) Low-Molecular-Weight Heparin Lowers the Recurrence Rate of Preeclampsia and Restores the Physiological Vascular Changes in Angiotensin-Converting Enzyme DD Women. Hypertension 45:1, pages 86-91.
Crossref
Crossref
Michael J. Paidas, De-Hui W. Ku & Yale S. Arkel. (2004) Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome. Clinics in Perinatology 31:4, pages 783-805.
Crossref
Crossref
Charles J. Glueck, Ping Wang, Naila Goldenberg & Luann Sieve. (2016) Pregnancy Loss, Polycystic Ovary Syndrome, Thrombophilia, Hypofibrinolysis, Enoxaparin, Metformin. Clinical and Applied Thrombosis/Hemostasis 10:4, pages 323-334.
Crossref
Crossref
Matthew F. Davies & Carie Ann D’Agata. (2004) Inherited Thrombophilia in Pregnancy. Postgraduate Obstetrics & Gynecology 24:18, pages 1-6.
Crossref
Crossref
Jody L. Kujovich. (2004) Thrombophilia and pregnancy complications. American Journal of Obstetrics and Gynecology 191:2, pages 412-424.
Crossref
Crossref
I. Martinelli. (2004) Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications. Journal of Thrombosis and Haemostasis 2:7, pages 1184-1185.
Crossref
Crossref
Benjamin Brenner. (2004) Clinical management of thrombophilia-related placental vascular complications. Blood 103:11, pages 4003-4009.
Crossref
Crossref
Jean-Christophe GrisEric MercierIsabelle QuéréGéraldine Lavigne-LissaldeEva Cochery-NouvellonMédéric HoffetSylvie Ripart-NeveuMarie-Laure TaillandMichel DauzatPierre Marès. (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103:10, pages 3695-3699.
Crossref
Crossref
Marta C. Wille, Beth Weitz, Peggy Kerper & Stephanie Frazier. (2004) Advances in Preconception Genetic Counseling. The Journal of Perinatal & Neonatal Nursing 18:1, pages 28-40.
Crossref
Crossref
SUSAN MURIN, LISA MOORES, KATHRYN L. BILELLO & RICHARD A. MATTHAY. 2004. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
332
346
.
Charles J Glueck, Ping Wang, Seref Bornovali, Naila Goldenberg & Luann Sieve. (2003) Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss. Metabolism 52:12, pages 1627-1632.
Crossref
Crossref
B. Brenner. (2003) Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes. Journal of Thrombosis and Haemostasis 1:10, pages 2070-2072.
Crossref
Crossref
Benjamin Brenner & Michael J Kupferminc. (2003) Inherited thrombophilia and poor pregnancy outcome. Best Practice & Research Clinical Obstetrics & Gynaecology 17:3, pages 427-439.
Crossref
Crossref
Michelle A Elliott & Ayalew Tefferi. (2003) Thrombocythaemia and pregnancy. Best Practice & Research Clinical Haematology 16:2, pages 227-242.
Crossref
Crossref
Amiram Eldor. (2002) The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 104:1, pages 3-13.
Crossref
Crossref